MA28394B1 - Derives d'heteroaryle pour traitement des virus - Google Patents

Derives d'heteroaryle pour traitement des virus

Info

Publication number
MA28394B1
MA28394B1 MA29128A MA29128A MA28394B1 MA 28394 B1 MA28394 B1 MA 28394B1 MA 29128 A MA29128 A MA 29128A MA 29128 A MA29128 A MA 29128A MA 28394 B1 MA28394 B1 MA 28394B1
Authority
MA
Morocco
Prior art keywords
viruses
treatment
heteroaryl derivatives
heteroaryl
derivatives
Prior art date
Application number
MA29128A
Other languages
English (en)
Inventor
Ulrich Schmitz Franz
Botyanszki Janos
Don Roberts Christopher
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of MA28394B1 publication Critical patent/MA28394B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA29128A 2005-06-24 2006-06-22 Derives d'heteroaryle pour traitement des virus MA28394B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69370005P 2005-06-24 2005-06-24

Publications (1)

Publication Number Publication Date
MA28394B1 true MA28394B1 (fr) 2007-01-02

Family

ID=37499598

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29128A MA28394B1 (fr) 2005-06-24 2006-06-22 Derives d'heteroaryle pour traitement des virus

Country Status (14)

Country Link
US (1) US20060293320A1 (fr)
EP (1) EP1910337A2 (fr)
JP (1) JP2008546802A (fr)
KR (1) KR20080040677A (fr)
CN (1) CN101223161A (fr)
AR (1) AR054797A1 (fr)
AU (1) AU2006261132A1 (fr)
BR (1) BRPI0612124A2 (fr)
CA (1) CA2613261A1 (fr)
MA (1) MA28394B1 (fr)
MX (1) MX2007016144A (fr)
PE (1) PE20070124A1 (fr)
TW (1) TW200726471A (fr)
WO (1) WO2006138744A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007100795A2 (fr) * 2006-02-27 2007-09-07 Gilead Colorado, Inc. Combinaisons thérapeutiques et méthodes pour amélioration cardio-vasculaire et traitement de maladie cardio-vasculaire
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
EP2142215B1 (fr) 2007-05-04 2012-03-07 Vertex Pharmceuticals Incorporated Thérapie combinée pour le traitement d'une infection par le vhc
CA2690192A1 (fr) * 2007-06-26 2008-12-31 Gilead Colorado, Inc. Inhibiteurs d'imidazopyridinyl-thiazolyl-histone desacetylase
WO2010009166A1 (fr) * 2008-07-14 2010-01-21 Gilead Colorado, Inc. Composés inhibiteurs de l’oxindolyle
CA2729909A1 (fr) * 2008-07-14 2010-01-21 Gilead Sciences, Inc. Composes inhibiteurs de pyrimidine imidazolyle
US8124764B2 (en) * 2008-07-14 2012-02-28 Gilead Sciences, Inc. Fused heterocyclyc inhibitor compounds
CN102123987A (zh) * 2008-07-28 2011-07-13 吉里德科学公司 亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物
ES2572615T3 (es) 2008-08-15 2016-06-01 Nivalis Therapeutics, Inc. Nuevos inhibidores pirrólicos de S-nitrosoglutatión reductasa como agentes terapéuticos
DK2315590T3 (da) * 2008-08-15 2012-11-19 N30 Pharmaceuticals Inc Pyrrolinhibitorer af S-nitrosoglutathionreduktase
US8470857B2 (en) * 2008-08-15 2013-06-25 N30 Pharmaceuticals, Inc. Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
CN102405047B (zh) 2009-01-30 2014-07-09 葛兰素史密斯克莱有限责任公司 结晶型的n-{(1s)-2-氨基-1-[(3-氟苯基)甲基]乙基}-5-氯-4-(4-氯-1-甲基-1h-吡唑-5-基)-2-噻吩甲酰胺盐酸盐
KR20120031170A (ko) * 2009-06-08 2012-03-30 길리애드 사이언시즈, 인코포레이티드 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
US8283357B2 (en) * 2009-06-08 2012-10-09 Gilead Sciences, Inc. Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
EA020031B1 (ru) * 2009-06-11 2014-08-29 Эббви Бахамаз Лтд. Противовирусные соединения
WO2011047390A2 (fr) 2009-10-16 2011-04-21 University Of Maryland, Baltimore County Compositions hétérocycliques de benzoxazole à titre d'inhibiteurs du virus de l'hépatite c
EA201200650A1 (ru) 2009-10-30 2012-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Курсы комбинированного лечения вируса гепатита с, включающие bi201335, интерферон-альфа и рибавирин
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
CA2813093A1 (fr) * 2010-09-30 2012-04-05 Boehringer Ingelheim International Gmbh Therapie combinee pour le traitement d'une infection par le vhc

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE69133402T2 (de) * 1990-04-04 2004-11-11 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Protease von hepatitis-c-virus
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE69434931T2 (de) * 1993-04-02 2007-11-22 Rigel Pharmaceuticals, Inc., South San Francisco Methode zur selektiven inaktivierung der viralen replication
IT1272179B (it) * 1994-02-23 1997-06-16 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
US5759795A (en) * 1996-03-08 1998-06-02 Schering Corporation Assay for determining inhibitors of ATPase
CA2283379A1 (fr) * 1997-03-05 1998-09-11 Michael G. Katze Nouveaux procedes de criblage permettant l'identification d'agents inhibant de maniere selective la replication du virus de l'hepatite c
CA2312484A1 (fr) * 1997-12-11 1999-06-17 Smithkline Beecham Corporation Proteine tronquee du virus ns5b de l'hepatite c et procedes associes d'identification de composes antiviraux
CO5271680A1 (es) * 2000-02-21 2003-04-30 Smithkline Beecham Corp Compuestos
EP2335700A1 (fr) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
MY151199A (en) * 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
EP1534273A4 (fr) * 2002-07-18 2007-08-22 Bristol Myers Squibb Co Modulateurs de recepteurs de glucocorticoides et procede associe
GB0307891D0 (en) * 2003-04-04 2003-05-14 Angeletti P Ist Richerche Bio Chemical compounds,compositions and uses
JP2007501189A (ja) * 2003-08-01 2007-01-25 ジェネラブス テクノロジーズ，インコーポレイテッド フラビウイルス科に対する二環式イミダゾール誘導体

Also Published As

Publication number Publication date
WO2006138744A3 (fr) 2007-04-05
MX2007016144A (es) 2008-03-06
AR054797A1 (es) 2007-07-18
CA2613261A1 (fr) 2006-12-28
WO2006138744A2 (fr) 2006-12-28
US20060293320A1 (en) 2006-12-28
BRPI0612124A2 (pt) 2010-10-19
PE20070124A1 (es) 2007-03-09
KR20080040677A (ko) 2008-05-08
AU2006261132A1 (en) 2006-12-28
JP2008546802A (ja) 2008-12-25
EP1910337A2 (fr) 2008-04-16
TW200726471A (en) 2007-07-16
CN101223161A (zh) 2008-07-16

Similar Documents

Publication Publication Date Title
MA28394B1 (fr) Derives d'heteroaryle pour traitement des virus
MA29097B1 (fr) Composes pour le traitement des infections virales par flaviviridae
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
EP1976516A4 (fr) Traitement de l'hépatite virale
EP2203168A4 (fr) Méthodes de traitement d'une infection par un virus de la famille des flaviviridae et compositions pour le traitement d'une infection par un virus de la famille des flaviviridae
MA29098B1 (fr) Compositions pour le traitement du vhc
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
EP1931691A4 (fr) Inhibiteurs d'odcase pour le traitement du paludisme
EP2120566A4 (fr) Composés et compositions pharmaceutiques destinés au traitement d'infections virales
EP2019825A4 (fr) Inhibiteurs de la réplication du virus de l'immunodéficience humaine
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP2001516A4 (fr) Vaccins pour des virus provoquant des infections persistantes ou latentes
EP1915054A4 (fr) Derives d'acetaux cycliques de ribonucleosides pour traiter une infection virale d'arn arn dependante
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
EP2376091A4 (fr) Nouvelles cibles pour le traitement de l'hypercholestérolémie
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE533774T1 (de) Neuartige nukleosidanaloge zur behandlung von virusinfektionen
ATE486597T1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
DK1709075T3 (da) Behandling af virusinfektioner
EP1881825A4 (fr) Inhibiteurs de l'intégrase du vih
EP2120988A4 (fr) Traitement de l'infection par le virus de l'hépatite c
PT1299395E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus